维普期刊资源整合服务平台（V6.5）

57篇 您的检索式：作者名="Piazza O"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Helicobacter pylori eradication: Sequential therapy and Lactobacillus reuteri supplementation显示文摘AIM:To evaluate the role of sequential therapy and Lactobacillus reuteri (L. reuteri ) supplementation, in the eradication treatment of Helicobacter pylori (H. pylori ). METHODS:H. pylori infection was diagnosed in 90 adult dyspeptic patients. Patients were excluded if previously treated for H. pylori infection or if they were taking a proton pump inhibitor (PPI), H2-receptor antagonist or antibiotics. Patients were assigned to receive one of the following therapies:(1) 7-d triple therapy (PPI plus clarithromycin and amoxicillin or metronidazole) plus L. reuteri supplementation dur- ing antibiotic treatment; (2) 7-d triple therapy plus L. reuteri supplementation after antibiotic treatment; (3) sequential regimen (5-d PPI plus amoxicillin therapy followed by a 5-d PPI, clarithromycin and tinidazole) plus L. reuteri supplementation during antibiotic treatment; and (4) sequential regimen plus L. reuteri supplementation after antibiotic treatment. Successful eradication therapy was defined as a negative urea breath test at least 4 wk following treatment. RESULTS:Ninety adult dyspeptic patients were en- rolled, and 83 (30 male, 53 female; mean age 57 ± 13 years) completed the study. Nineteen patients were administered a 7-d triple treatment:11 with L. reuteri supplementation during and 8 after therapy. Sixty-four patients were administered a sequential regimen:32 with L. reuteri supplementation during and 32 after therapy. The eradication rate was significantly higher in the sequential group compared with the 7-d triple regimen (88% vs 63%, P = 0.01). No difference was found between two types of PPI. No difference in erad- ication rates was observed between patients submitted to L. reuteri supplementation during or after antibiotic treatment. Compliance with therapy was excellent in all patients. No difference in adverse effects was observed between the different antibiotic treatments and between patients submitted to L. reuteri supplementation during and after antibiotic treatment. There was a low incidence of adverse effects in all groups of patients with sequential therapy, probably due to the presence of the L. reuteri supplementation. CONCLUSION:The sequential treatment regimen achieved a significantly higher eradication rate of H. pylori compared with standard 7-d regimen. L. reuteri supplementation could reduce the frequency and the intensity of antibiotic-associated side-effects.	Cesare Efrati Giorgia Nicolini Claudio Cannaviello Nicole Piazza O'Sed Stefano Valabrega	2012	World Journal of Gastroenterology2012，18，43：	4
2	Thrombin antithrom- bin complex and IL-18 serum levels in stroke patients 显示文摘	Piazza O Scarpati G Cotena S	2010	Neurol Int2010，2，1：	1
3	The use oferythropoietin in cerebral diseases显示文摘	Cotena S Piazza O Tufano R	2008	Panminerva-Med2008，50，2：	1
4	What is the best test to predict outcome after prolonged cardiac arrest 显示文摘	Sandroni C Barelli A Piazza O	1995	Eur Emcrg Med1995，2，1：	1
5	Toll - like receptor kinetics in septic shock patients: a preliminary study显示文摘	Piazza O Pulerano G Fiori PL	2012	Int J Immunopathol Pharmaeol2012，25，2：	1
6	Terlipressin in brain-death donors显示文摘	Piazza O Scarpati G Rispoli F	2012	Clin Transplant2012，2，12：	1
7	The use of erythtropoietin in cerebral diseases显示文摘	Cotena S Piazza O Tufano R		0，，02：	1
8	Percutaneoustranscatheter mitral valve replacement: an overview ofdevices in preclinical and early clinical evaluation 显示文摘	De Backer O Piazza N Banai S	2014	CircCardiovasc Interv2014，7，3：	1
9	Thrombin antithrom- bin complex and IL-18 serum levels in stroke patients 显示文摘	Piazza O Scarpati G Cotena S	2010	Neurol Int2010，2，1：	1
10	Hemispheric Cerebellar rTMS to Treat Drug-resistant Epilepsy:Case Reports显示文摘	BRIGHINA F DANIELE O PIAZZA A	2006	Neurosci Lett(S0304-3940)2006，397，3：	1
11	Prognosis of isolated acute post-traumatic subdural haematoma显示文摘	D'Amato L Piazza O Alliata L	2007	J Neurosurg Sci2007，51，3：	1
12	S100B in Guillain-Barre syndrome 显示文摘	Piazza O Esposito G De Robertis E	2006	Br J Anaesth2006，96，1：	1
13	The use of erythtropoietin in cerebral diseases 显示文摘	Cotena S Piazza O Tufano R	2008	Panminerva Med2008，50，2：	1
14	S100B in Guillain-Barre syndrome显示文摘	Piazza O Esposito G De Robertis E	2006	British Journal of Anaesthesia2006，96，1：	1
15	The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of o- varian carcinoma cells显示文摘	Rosso O Piazza T Bongarzone I	2007	Mol Cancer Res2007，5，12：	1
16	Candidemia in intensive care patients显示文摘	Piazza O Boccia MC Iasiello A	2004	Risk Factors and Mortality Minerva Anestesiol2004，70，12：	1
17	lntra-abdominal hypertension is not reliable as an early predictor of mortality in the intensive care unit 显示文摘	Lonardo M Piazza O De Marco G	2007	Minerva anestesiologica2007，73，9：	1
18	Narrow-band imaging: a new tool for evaluation of head and neck squamous cell carcinomas显示文摘	Piazza C Dessouky O Peretti G	2008	Acta Otorhinolaryngol Ital2008，28，2：	1
19	The use of eryth tropoietin in cerebial diseases显示文摘	Cotena S Piazza O Tufano R	2008	Panminerva Med2008，50，：	1
20	S100B is a sensitive but not specific prognostic index in comatose patients after cardiac arrest显示文摘	Cotena S Esposito G	2005	Minerva Chir2005，60，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示